IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Dishman Signs API Development Deal with Polish Firm

4:48 AM MDT | March 25, 2009 | Deepti Ramesh

Dishman Pharmaceuticals & Chemicals (Ahmedabad, India) says it has signed a cooperation and joint active pharmaceuticals ingredients (API) development agreement with Polpharma (Starogard GdaƄski, Poland), a manufacturer of APIs and finished dosage forms. Polpharma is a strong player in its home market and a leader in the Central and Eastern European markets and Commonwealth of Independent States (CIS) countries, Dishman says. “Such partnerships will ensure long term API manufacturing contracts to Dishman and also provide API development and DMF (drug...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa